NINDS Neuroscience Funding Announcements

Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transtion by registering with Grants.gov and NIH eRA Commons now.

---

Development of In-Vitro Assays to Assess the Potency of Botulinum Neurotoxin Type A (SBIR [R43/R44])
Release Date: April 29, 2009
Announcement Number: PA-09-179
Application Receipt Date:
August 5, 2009
December 5, 2009
April 5, 2010
August 5, 2010
December 5, 2010
April 5, 2011
August 5, 2011
December 5, 2011
April 5, 2012   

Funding Contact: Danilo Tagle, Ph.D.
Program Area: Neurogenetics

Brief Description:
This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop new non-animal-based assays to assess the potency of botulinum neurotoxin type A (BoNT/A) in a Good Manufacturing Practice (GMP) commercial environment. Successful projects should have as their goal the development of a test(s) and reagents that could be used for commercial release testing of BoNT/A products.

Choose an option to view additional funding announcements

New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives